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Abstract 18 
Objectives: To compare the postprandial cardiometabolic response to prolonged sedentary 19 
time, continuous moderate-intensity physical activity (PA) followed by prolonged sedentary 20 
time, and interrupting prolonged sedentary time with hourly high-intensity PA breaks. Design: 21 
Three-condition randomised crossover trial. Methods: Fourteen sedentary and inactive adults 22 
aged 29 ± 9 years took part in three, 8-h conditions: 1) prolonged sitting (SIT), 2) a continuous 23 
30-min moderate-intensity PA bout followed by prolonged sitting (CONT-SIT), and 3) sitting 24 
interrupted hourly with 2 min 32 s high-intensity PA bouts (SIT-ACT). The treadmill PA in 25 
conditions 2 and 3 were matched for energy expenditure. Two standardised test meals were 26 
consumed during each condition. Incremental area under the curve (iAUC) for each 8-h 27 
condition was calculated for glucose, insulin, triglyceride, and high-density lipoprotein 28 
cholesterol (HDL-C) concentrations. Statistical analyses were completed using linear mixed 29 
models. Results: Compared with SIT, SIT-ACT lowered triglyceride iAUC by 2.23 mmol/L∙8 h 30 
(95% CI -4.33, -0.13) and raised HDL-C iAUC by 0.99 mmol/L∙8 h (0.05, 1.93) (all p≤0.038). 31 
There was no significant difference in triglyceride or HDL-C iAUC between CONT-SIT and SIT 32 
or SIT-ACT (p≥0.211). There were no significant differences between conditions for glucose 33 
or insulin iAUC (p≥0.504). Conclusions: This study suggests that interrupting prolonged sitting 34 
with hourly high-intensity PA breaks acutely improves postprandial triglyceride and HDL-C 35 
concentrations compared with prolonged sitting, whereas a continuous moderate-intensity PA 36 
bout does not. 37 
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Introduction 59 
Cardiometabolic diseases, such as type 2 diabetes and cardiovascular disease (CVD), are 60 
highly prevalent in modern society.1 These diseases are associated with poor regulation of 61 
postprandial triglyceride, glucose and insulin, which can cause oxidative stress, inflammation, 62 
and endothelial dysfunction, subsequently increasing cardiometabolic disease risk.2 Thus, 63 
interventions to reduce fluctuations in these cardiometabolic risk markers are important, 64 
particularly as the waking day is predominantly spent in a postprandial state.  65 
 66 
Although engaging in ≥60 minutes per day of moderate intensity physical activity (PA) may 67 
offset the increased mortality risk associated with high sitting time,3 higher total sedentary time 68 
and lower number of interruptions in sedentary time are often associated with increased 69 
cardiometabolic disease risk independent of moderate-to-vigorous PA (MVPA).4,5 Acute 70 
experimental studies report beneficial postprandial triglyceride, glucose and insulin responses 71 
to interrupting prolonged sitting every 20-30 min with light or moderate-intensity PA.6-8 When 72 
sitting is interrupted less frequently (i.e., hourly) with moderate-intensity cycling, postprandial 73 
glucose, triglyceride, and high-density lipoprotein cholesterol (HDL-C) concentrations were 74 
not affected compared with uninterrupted sitting.9,10 However, continuous moderate-intensity 75 
PA may not increase skeletal muscle GLUT4 expression and lipoprotein lipase activity to the 76 
same extent as high-intensity PA.11,12 Thus, although interrupting sitting with moderate-77 
intensity PA every 30-min reduces postprandial glucose,8 higher-intensity PA may be 78 
necessary if sitting is interrupted hourly. Additionally, the limited active muscle mass with 79 
hourly PA interruptions may have been insufficient for stimulating whole-body glucose and 80 
lipid metabolism.9,10 81 
 82 
Interrupting sitting may have similar or more pronounced cardiometabolic effects than 83 
continuous moderate-intensity PA in various populations.7,8 Reductions in postprandial 84 
glucose and insulin concentrations were observed when sitting was interrupted with moderate-85 
intensity walking compared with a single, continuous energy and intensity-matched PA bout 86 
performed in the morning in healthy, normal weight adults.8 Interrupting sitting with moderate-87 
intensity walking also attenuated postprandial triglycerides to a similar extent as a continuous 88 
energy and intensity-matched PA bout performed in the morning in postmenopausal women.7 89 
The postprandial cardiometabolic response to interrupting sitting with high-intensity PA 90 
compared with an energy-matched continuous moderate-intensity PA bout has not been 91 
studied in any population. Therefore, this study compared the postprandial cardiometabolic 92 
response to prolonged sitting, continuous moderate-intensity PA followed by prolonged sitting, 93 
and interrupting sitting with hourly high-intensity PA. 94 
 95 
Methods  96 
This was a three-condition randomised crossover trial approved by the University of 97 
Bedfordshire Institute for Sport and Physical Activity Research Ethics Committee (approval 98 
number 2015ISPAR004). All testing took place at the University of Bedfordshire Sport and 99 
Exercise Science Laboratories. Fourteen (seven female) sedentary and inactive adults (self-100 
reported sitting ≥7 h/day and MVPA <150 min/week) aged 18-55 years gave informed consent 101 
to participate. Exclusion criteria were any known blood borne disease, pregnancy, diabetes, 102 
taking glucose-lowering and/or lipid-lowering medication, known PA contraindications, major 103 
illness/injury, allergies to the test meals being provided, or other health issues that may limit 104 
the ability to perform the necessary activity bouts. 105 
 106 
Sample size estimations were based on postprandial glucose and triglyceride incremental 107 
area under the curve (iAUC). Based on an effect size of F=0.61 for change in postprandial 108 
glucose,13 10% within-group error variance, a within-person correlation of 0.6, 90% power, 109 
and α=0.05, it was estimated that nine participants would be required for this study. Using 110 
these same parameters, but with an effect size of F=0.45 for postprandial triglycerides,14 it 111 
was estimated that 12 participants would be required. To allow for dropout, 14 participants 112 
were recruited.  113 
 114 
Stature was measured using a stadiometer (Holtain Ltd., Crymych, Wales). Body mass and 115 
body fat were measured using the Tanita BC-418 Segmental Body Composition Analyzer 116 
(Tanita Corp., Tokyo, Japan). Participants were then familiarised with the Borg Rating of 117 
Perceived Exertion (RPE) scale15 and completed a maximal oxygen uptake (V̇O2max) test on a 118 
motorised treadmill (Woodway PPS55Med-I, GmbH, Germany). Expired air was measured 119 
continuously using an online gas analysis (Cortex Metalyzer 3B, GmbH, Germany). 120 
Participants began the test with a 3-min stage at a speed they could comfortably maintain for 121 
30-min. This was then increased by 1 km/h every 3-min until volitional exhaustion. V̇O2max was 122 
taken as the highest V̇O2 value averaged over a 10 s period and was accepted as having been 123 
achieved when meeting ≥2 of the following end-point criteria: 1) heart rate within 10 bpm of 124 
age predicted maximum (220 – age), 2) respiratory exchange ratio >1.15, 3) plateau of V̇O2 125 
despite increasing workload, and 4) RPE ≥18. Subsequently, the V̇O2 (mL∙kg-1∙min-1) 126 
representing 60% and 85% V̇O2 Reserve (V̇O2R) were determined and the treadmill speeds 127 
corresponding to these intensities were estimated and used for the experimental conditions.  128 
 129 
After preliminary measures, participants completed three, 8-h experimental conditions 130 
separated by washout periods of 6-35 days and conducted in an incomplete counterbalanced 131 
order pre-determined using the Latin square method (see Figure 1). The washout period was 132 
longer for females to ensure the experimental conditions were completed during the follicular 133 
phase only to minimise the effects of the menstrual cycle on cardiometabolic outcomes.16 The 134 
conditions were as follows: 135 
 136 
1) Prolonged sitting (SIT): participants remained seated throughout the experimental period.  137 
2) Continuous moderate-intensity PA followed by prolonged sitting (CONT-SIT): after 30-min 138 
rest, participants completed a 30-min continuous moderate-intensity PA bout (60% V̇O2R) 139 
followed by prolonged sitting for the remainder of the condition.  140 
3) Sitting interrupted with high-intensity PA breaks (SIT-ACT): after 30-min rest, participants 141 
completed 2 min 32 s bouts of high-intensity PA (85% V̇O2R) at 60-min intervals. This 142 
resulted in eight bouts equalling a total of 20 min 16 s PA. 143 
 144 
To match PA energy expenditure between CONT-SIT and SIT-ACT, it was estimated that 20 145 
min 16 s of PA at 85% V̇O2R would elicit similar energy expenditure to 30-min of PA at 60% 146 
V̇O2R.17 The 20 min 16 s of PA during SIT-ACT was spread equally across the eight hourly 147 
bouts, resulting in a bout duration of 2 min 32 s. This approach ensured that the PA bout 148 
duration and proximity of PA bouts to the blood samples were standardized between 149 
participants. All PA was performed on a motorised treadmill. 150 
 151 
Participants were asked to refrain from exercise, alcohol, and caffeine in the 48-h before each 152 
experimental condition, which was confirmed verbally upon arrival. Participants weighed and 153 
recorded all food and liquid intake in a food diary for 24-h before the first experimental 154 
condition. The quantity and timings were then replicated prior to each subsequent 155 
experimental condition. All participants attended the laboratory at ~0800 h after an overnight 156 
fast and were instructed to minimise PA during their commute. Upon arrival, participants were 157 
fitted with an Actiheart monitor (CamNtech Ltd., Cambridge, UK) to provide a valid and reliable 158 
estimate of PA energy expenditure throughout each experimental condition.18 The monitor 159 
was individually calibrated using expired air data from the V̇O2max test. Subsequently, 160 
participants had a cannula (Vasofix, B. Braun Medical Ltd, Sheffield, UK) inserted into an 161 
antecubital vein and a fasting blood sample was collected. A standardised breakfast meal was 162 
then consumed and the 8-h experimental condition commenced following the last mouthful. A 163 
second standardised meal was consumed at 4-h. Participants were permitted to void when 164 
needed during each condition. The toilets were located ~30 m from the laboratory. Participants 165 
were supervised throughout the conditions to ensure adherence to the protocols and were 166 
permitted to watch DVDs, read, talk, or work on a laptop when seated. During sitting periods, 167 
participants were asked to minimise excessive movement. 168 
 169 
The standardised breakfast and lunch meals provided 15% and 30%, respectively, of 170 
individual daily energy requirements estimated using the Mifflin equation19 with a PA factor of 171 
1.4 applied to represent a sedentary day. The Mifflin equation19 provides a more accurate 172 
estimation of resting energy expenditure than other commonly used prediction equations.20 173 
Both meals consisted of cornflakes and whole milk, contained 55% carbohydrate, 30% fat, 174 
and 15% protein and had a high glycaemic index (79). The mean carbohydrate, fat, and protein 175 
content was 47±8 g, 11±2 g, and 13±2 g for breakfast and 71±12 g, 17.2±3 g, and 19±3 g for 176 
lunch. Participants were asked to consume each meal within 15-min. During the first 177 
experimental condition, consumption times were recorded and participants were asked to 178 
replicate this as closely as possible in each subsequent condition. Water was provided ad 179 
libitum during the first condition and the volume consumed was replicated during subsequent 180 
conditions. 181 
 182 
Venous blood samples were collected via cannulation in the fasted state and then hourly into 183 
two 4.9 mL EDTA-containing vacuettes (Vacuette, Greiner Bio-One, Austria). Whole blood 184 
was pipetted in volumes of 50 µl from one vacuette into a microvette and analysed immediately 185 
in duplicate to determine blood glucose concentrations using the YSI 2300 STAT plus glucose 186 
and lactate analyzer (YSI Inc., Yellow Springs, OH, USA). Further volumes of 30 µl of whole 187 
blood were aliquoted onto two separate Reflotron test strips (Roche Diagnostics, Burgess Hill, 188 
UK) for the determination of triglyceride and HDL-C concentrations using the Reflotron Plus 189 
system (Roche Diagnostics, Burgess Hill, UK). The vacuettes were then spun using a 190 
refrigerated centrifuge (Heraeus, Heraeus Multifuge X3R, Thermo Scientific) at 1500 x g for 191 
10-min at 4oC. The plasma was stored at -80oC for later batch analysis of insulin using an 192 
enzyme-linked immunosorbent assay kit (Mercodia, Uppsala, Sweden). The intra-assay and 193 
inter-assay CVs were 9.4% and 12.2%, respectively. 194 
 195 
The primary outcomes were net iAUC for the cardiometabolic variables as this method is most 196 
appropriate for describing postprandial glycaemic and lipaemic responses.21,22 Total AUC 197 
(tAUC) was calculated using the trapezoidal method to permit comparisons with previous 198 
research.7,13,14 The net iAUC was calculated by subtracting the area under the baseline 199 
concentration from the tAUC. 200 
 201 
Statistical analyses were completed using SPSS version 22.0 (SPSS INC., Armonk, N.Y., 202 
USA). Normality assumptions were assessed using Quantile-Quantile plots. Linear mixed 203 
models were used to determine any differences in the dependent variables between 204 
conditions. Condition and covariates (age, gender, body fat%, and fasting outcome values) 205 
were fixed factors and participants were random factors within all models analysing 206 
cardiometabolic outcomes. No covariates were entered into the models when comparing PA 207 
energy expenditure between conditions as age, gender, and body mass index are used in the 208 
algorithms to estimate PA energy expenditure. Sidak correction for multiple comparisons was 209 
used for post-hoc analysis when a significant main effect was present. Cohens’ d effect sizes 210 
were calculated to describe the magnitude of differences between conditions; 0.2, 0.5 and 0.8 211 
indicated a small, medium and large effect.  Data are presented as mean (95% confidence 212 
interval [CI]) unless stated otherwise. Statistical significance was accepted as p≤0.05.  213 
 214 
Results 215 
Table 1 shows the descriptive characteristics of the participants. Total PA energy expenditure 216 
did not differ significantly (p=0.236) between CONT-SIT (661 kJ; 476, 828) and SIT-ACT (732 217 
kJ; 539, 891). Table 2 shows fasting concentrations, iAUC and tAUC for each cardiometabolic 218 
risk marker and Figure 2 (supplementary material) shows cardiometabolic risk marker 219 
responses over time for each condition. Fasting concentrations did not differ significantly 220 
between conditions (Table 2).  221 
 222 
There was a significant main effect of condition for triglyceride iAUC (Table 2). Triglyceride 223 
iAUC was reduced by 2.23 mmol/L∙8 h in SIT-ACT compared with SIT (p=0.035) with a 224 
medium effect size for this difference (d=0.62). No significant difference was observed 225 
between SIT and CONT-SIT (p=0.361; d=0.35) or between CONT-SIT and SIT-ACT (p=0.580; 226 
d=0.27) with small effect sizes. There was a trend for triglyceride tAUC being lower in SIT-227 
ACT than SIT (p=0.073). There was a significant main effect of condition for HDL-C iAUC with 228 
concentrations being 0.99 mmol/L∙8 h higher in SIT-ACT than SIT with a medium effect size 229 
(p=0.037; d=0.64). No significant differences were observed between SIT and CONT-SIT 230 
(p=0.813; d=0.20) or between CONT-SIT and SIT-ACT (p=0.211; d=0.44) with small effect 231 
sizes (Table 2). There was no main effect of condition for HDL-C tAUC. The main effect of 232 
condition for glucose and insulin iAUC and tAUC was not significant. 233 
 234 
Discussion 235 
The novel findings of this study were that interrupting sitting with short, hourly bouts of high-236 
intensity PA improved postprandial triglyceride and HDL-C concentrations compared with 237 
uninterrupted sitting in sedentary adults, whereas a continuous moderate-intensity PA bout 238 
followed by prolonged sitting did not. 239 
 240 
The reduction in postprandial triglyceride concentrations in response to interrupting sitting with 241 
high-intensity PA compared with prolonged sitting reported here is congruent with previous 242 
research where postmenopausal women engaged in moderate-intensity walking for 1 min 30 243 
s every 15-min7 and obese men engaged in moderate-intensity cycling for 3-min every 30-244 
min.14 However, other studies where sitting was interrupted with moderate-intensity walking 245 
for 1 min 40 s every 30-min in healthy, normal weight adults8 and moderate-intensity cycling 246 
for 8-min every hour in young healthy adults9 did not attenuate postprandial triglycerides, 247 
possibly because the combination of frequency, duration and intensity of interruptions in sitting 248 
were not sufficient. Alternatively, metabolically healthy participants may not respond to 249 
interruptions in sitting8,9 compared with postmenopausal women,7 obese men,14 and our 250 
sedentary and inactive sample who had a relatively higher body fat%. Furthermore, 251 
attenuation of postprandial triglyceride concentrations in response to interrupting sitting with 252 
moderate-intensity PA may be delayed due to the activity of lipoprotein lipase typically peaking 253 
8-22 h after a single bout of moderate-intensity PA.23 Given the findings of the present study, 254 
it is possible that interrupting sitting regularly may acutely attenuate the decrease in lipoprotein 255 
lipase activity that occurs rapidly in response to physical inactivity in animal models.24 Thus, 256 
further research examining lipoprotein lipase in response to interrupting sitting in humans 257 
would be valuable. 258 
 259 
The increase in postprandial HDL-C net iAUC in response to interrupting sitting may be due 260 
to triglyceride-rich lipoproteins undergoing hydrolysis and losing surface phospholipids that 261 
are acquired by HDL-C.25 This increase was not shown in previous studies that measured 262 
HDL-C only at the end of the experimental periods,13,26 indicating that regular measurements 263 
across the postprandial period are required to detect significant or potentially meaningful 264 
effects. In contrast to our findings, a decrease in HDL-C and increase in triglycerides has been 265 
reported in response to interrupting sitting every 40-min with 6-min high-intensity (70% V̇O2max) 266 
cycling in young females.26 Thus, treadmill PA, which is weight-bearing and incorporates upper 267 
and lower body muscle contractions, as used in the present study, may be necessary to benefit 268 
lipid metabolism.26 However, HDL-C tAUC did not differ between conditions in the present 269 
study. Thus, net iAUC, where only the data above baseline are included and the data that drop 270 
below baseline are subtracted from the response, may be more sensitive for detecting 271 
between-condition effects. Although iAUC is most appropriate for describing postprandial 272 
lipaemic responses,22 tAUC may have physiological relevance and should be examined in 273 
future research. 274 
 275 
The present study did not observe a beneficial change in postprandial lipids in response to a 276 
single continuous bout of moderate-intensity PA with a duration and intensity that aligned to 277 
current PA guidelines.27 Similar to the present study, postprandial triglyceride concentrations 278 
were not attenuated in response to a continuous 30-min moderate-intensity walking bout 279 
compared with prolonged sitting.8 However, other research has reported beneficial triglyceride 280 
responses to both continuous 30-min moderate-intensity PA bouts and interrupting sitting with 281 
ten, 3-min bouts of moderate-intensity PA every 30-min.14,28 Importantly, the postprandial test 282 
meal challenge in these two studies14,28 was performed 17-h following PA engagement, which 283 
may have permitted a longer duration for lipid metabolism in the presence of elevated 284 
lipoprotein lipase activity.23 Collectively, these findings suggest that reductions in postprandial 285 
lipaemia do not occur during a 7-8 h sitting period after engagement in a continuous 30-min 286 
moderate-intensity PA bout. 287 
 288 
Interrupting sitting with hourly high-intensity PA did not affect postprandial glucose or insulin, 289 
which is in agreement with previous research where sitting was interrupted hourly with 8-min 290 
moderate-intensity cycling.9 However, the majority of research has reported beneficial glucose 291 
and insulin responses to interrupting sitting with light or moderate-intensity PA for 2-5 min 292 
every 20-30 min.8,13 Thus, the hourly interruptions in sitting time in the present study and 293 
previous research9 may not have been frequent enough to upregulate the physiological 294 
mechanisms responsible for glucose disposal, such as translocation of the intracellular 295 
glucose transporter protein GLUT-4 and permeability of muscles cells to glucose.29  296 
 297 
When considering clinical relevance, postprandial dyslipidaemia is associated with oxidative 298 
stress that triggers a plethora of atherogenic changes and increases CVD risk.2 Thus, 299 
engaging in short high-intensity PA bouts may provide a time efficient, effective strategy to 300 
reduce CVD risk and may be particularly appealing for individuals who find it difficult to engage 301 
in continuous moderate-intensity PA. However, our sample were in good general health; thus, 302 
the findings may not be generalised to clinical populations at high risk of CVD. Further 303 
limitations of the present study are that a single high-intensity PA bout was not included for 304 
comparison to isolate the effects of PA frequency from intensity on cardiometabolic health. 305 
However, continuous high-intensity PA may not be feasible in sedentary populations due to 306 
lower cardiorespiratory fitness and enjoyment.30 Although fasting cardiometabolic outcomes 307 
did not differ between conditions, the control of menstrual cycle phase over three conditions 308 
could have meant that metabolic changes occurred in female participants over the course of 309 
the study (~3 months). It may have also been more appropriate to objectively confirm 310 
adherence to diet and PA controls before each experimental condition and to have collected 311 
blood immediately before the PA breaks to minimise any residual effects from the previous 312 
break. Lastly, this study was conducted in a controlled laboratory environment. Future 313 
research should evaluate the effects of interrupting sitting in real-life settings, such as at home 314 
or the workplace, where high-intensity PA may be less feasible than lower intensities, although 315 
this potential disadvantage may be offset by the lower frequency of PA breaks required. 316 
 317 
Conclusion 318 
In conclusion, interrupting sitting with hourly high-intensity PA acutely improves postprandial 319 
triglyceride and HDL-C concentrations when compared with prolonged sitting, whereas an 320 
energy-matched continuous moderate-intensity PA bout followed by prolonged sitting does 321 
not. Interrupting sitting with high-intensity PA may, therefore, be a potential strategy to reduce 322 
cardiometabolic disease risk in sedentary and inactive adults.  323 
 324 
Practical implications 325 
• Interrupting sitting with short high-intensity physical activity breaks every hour acutely 326 
improves cardiometabolic disease risk markers. 327 
• The long term cardiometabolic health benefits associated with engaging in 30-minutes 328 
of moderate-intensity physical activity per day may not be seen acutely. 329 
• Avoiding prolonged periods of sitting is recommended to reduce cardiometabolic 330 
disease risk. 331 
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Table 1 Descriptive participant characteristics (n=14) 420 
Characteristics Mean ± SD 
Age (years) 29 ± 9 
Height (cm) 172.8 ± 5.9 
Weight (kg) 78.5 ± 20.4 
Body mass index (kg/m2) 26.1 ± 5.8 
Body fat (%) 
Maximum oxygen uptake (mL·kg–1·min–1)  
26.1 ± 7.5 
38.6 ± 4.2 
421 
Table 2 Cardiometabolic risk marker values for each condition 422 
Variable SIT CONT-SIT SIT-ACT 
Fasting triglycerides (mmol/mL) 1.24 (0.92, 1.56) 1.48 (1.16, 1.81) 1.29 (0.95, 1.62) 
Fasting HDL-C (mmol/mL) 1.10 (0.93, 1.27) 0.88 (0.71, 1.05) 0.99 (0.81, 1.16) 
Fasting blood glucose (mmol/L) 4.32 (4.09, 4.55) 4.46 (4.23, 4.68) 4.33 (4.10, 4.55) 
Fasting plasma insulin (μU/mL) 8.02 (4.91, 11.1) 7.19 (4.08, 10.3) 10.2 (7.13, 13.4) 
Triglyceride iAUC (mmol/L∙8 h)* 1.36 (-0.46, 3.17) 0.11 (-1.72, 1.94) -0.88 (-2.73, 0.97) 
Mean differencea compared with SIT - -1.24 (-3.34, 0.86) -2.23 (-4.33, -0.13) 
Mean differencea compared with CONT-SIT - - -0.99 (-3.18, 1.20) 
Triglyceride total AUC (mmol/L∙8 h) 11.95 (10.47, 13.42) 10.56 (9.07, 12.05) 9.60 (8.08, 11.13) 
Mean differencea compared with SIT - -1.38 (-3.88, 1.12) -2.34 (-4.85, 0.17) 
Mean differencea compared with CONT-SIT - - -0.96 (-3.50, 1.59) 
HDL-C iAUC (mmol/mL∙8 h)* -0.13 (-0.91, 0.66) 0.18 (-0.61, 0.96) 0.86 (0.08, 1.65) 
Mean differencea compared with SIT - 0.30 (-0.68, 1.28) 0.99 (0.05, 1.93) 
Mean differencea compared with CONT-SIT - - 0.69 (-0.27, 1.64) 
HDL-C total AUC (mmol/mL∙8 h) 7.98 (6.99, 8.97) 7.67 (6.68, 8.65) 8.38 (7.39, 9.37) 
Mean differencea compared with SIT - -0.31 (-1.27, 0.65) 0.40 (-0.52, 1.32) 
Mean differencea compared with CONT-SIT - - 0.71 (-0.21, 1.63) 
Blood glucose iAUC (mmol/L∙8 h) 0.36 (-1.18, 1.90) -0.27 (-1.93, 1.38) 0.82 (-0.82, 2.46) 
Mean differencea compared with SIT - -0.64 (-3.30, 2.03) 0.46 (-2.17, 3.08) 
Mean differencea compared with CONT-SIT - - 1.09 (-1.74, 3.92) 
Blood glucose total AUC (mmol/L∙8 h) 35.40 (33.89, 36.91) 34.86 (33.30, 36.41) 35.65 (34.14, 37.15) 
Mean differencea compared with SIT - -0.54 (-2.68, 1.59) 0.25 (-1.78, 2.27) 
Mean differencea compared with CONT-SIT - - 0.79 (-1.34, 2.92) 
Plasma insulin iAUC (μU/mL∙8 h) 183.1 (138.7, 227.5) 177.9 (133.3, 222.5) 159.7 (114.8, 204.6) 
Mean differencea compared with SIT - -5.2 (-45.4, 35.0) -23.4 (-76.9, 30.2) 
Mean differencea compared with CONT-SIT - - -18.2 (-61.5, 25.1) 
Plasma insulin total AUC (μU/mL∙8 h) 201.5 (159.5, 243.4) 198.7 (156.5, 240.9) 178.1 (135.5, 220.8) 
Mean differencea compared with SIT - -2.7 (-49.5, 44.1) -23.3 (-72.1, 25.4) 
Mean differencea compared with CONT-SIT - - -20.6 (-70.6, 29.3) 
Data are mean (95% CI). SIT, prolonged sitting; CONT-SIT, continuous moderate-intensity physical activity followed by prolonged 423 
sitting; SIT-ACT, sitting interrupted with high-intensity physical activity; HDL-C, high-density lipoprotein cholesterol; iAUC, incremental 424 
area under the curve. 425 
aEstimated from pairwise comparisons of marginal means adjusted for age, gender, body fat% and fasting values for each biochemical 426 
measure. 427 
*Denotes a significant main effect of condition (p<0.05) 428 
Bold text indicates a significant pairwise comparison (p<0.05) 429 
 430 
 431 
 432 
 433 
Figure 1. Schematic of experimental protocol. PA, physical activity. 434 
 435 
 436 
Figure 2 (supplementary). Changes in triglycerides (A), high-density lipoprotein cholesterol 437 
(HDL-C) (B), glucose (C), and insulin concentrations during the prolonged sitting (SIT), 438 
continuous moderate-intensity physical activity followed by prolonged sitting (CONT-SIT), 439 
and sitting interrupted with high-intensity physical activity (SIT-ACT) conditions. Data are 440 
mean and 95% confidence interval. Some error bars have been omitted for clarity. 441 
 442 
